Are there differences between progression-free survival, relapse-free survival, and recurrence-free survival? | ResearchGate
Clinical Trial Endpoints in Cancer Research: Four Terms You Should Know
Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma
Progression-free survival and overall survival. Progression-free... | Download Scientific Diagram
Frontiers | Evaluation of Event-Free Survival Surrogating Overall Survival as the Endpoint in Neoadjuvant Clinical Trials of Gastroesophageal Adenocarcinoma
Understanding Event-Free Survival (EFS) After Treatment
Study design OpACIN, event-free survival and overall survival of... | Download Scientific Diagram
Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review | Leukemia
Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy | Journal of Clinical Oncology
A correlation analysis to assess event-free survival as a trial-level surrogate for overall survival in early breast cancer - eClinicalMedicine
Association between event-free survival and overall survival in early-stage triple-negative breast cancer | Future Oncology
Are progression-free and disease-free survival the new gold standard for cancer trials? | Cancer World Archive
Event-free survival > Overall survival? - data analysis - Datamethods Discussion Forum
The Importance of Disease-Free Survival as a Clinical Trial Endpoint: A Qualitative Study Among Canadian Survivors of Lung Cancer | The Patient - Patient-Centered Outcomes Research
Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? | Semantic
Disease Free Survival - an overview | ScienceDirect Topics
Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review | Leukemia
Exploring the relationship between Overall Survival (OS), Progression Free Survival (PFS) and Objective Response Rate (ORR) in patients with advanced melanoma - ScienceDirect
The Kaplan–Meier analysis of 5-year event-free survival and overall... | Download Scientific Diagram
Association of progression-free or event-free survival with overall survival in diffuse large B-cell lymphoma after immunochemotherapy: a systematic review | Leukemia
Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy | Journal of Clinical Oncology